Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Ginkgo Bioworks

Biotech & Life Sciences · Boston, United States · Founded 2008 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$568M
Market cap · May/2026
Revenue
$170M
Latest reported FY

Uses the most advanced technology on the planet – biology – to grow products instead of manufacturing them

Investors

22 investors on Ginkgo Bioworks's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage
Series A 6 investors entered at this stage
OS Fund
Vast Ventures
David Beyer
iGlobe Partners
Ian McNish
Felicis
Series B+ 12 investors entered at this stage
Starling Ventures
Illumina
Bill Gates
Senator Investment Group
Viking Global Investors
T. Rowe Price
Baillie Gifford
General Atlantic
Allen & Company
11.2 Capital
Cascade Investment
MicroVentures

Global footprint

Where Ginkgo Bioworks has talent and traffic

AI talent share
3.8% of workforce is AI talent
(22 of 578 staff)
Core AI61.04%
Other AI162.77%
Non-AI workforce55696.19%
Workforce by country
🇺🇸 United States · Boston HQ
Book a demo for the full country breakdown
Web traffic by country
9.5K monthly visits
across markets
🇺🇸 United States33.7%
🏳️ Korea30.5%
🏳️ Republic of15.8%
🇬🇧 United Kingdom11.6%
🇮🇳 India8.4%
Top 5 markets shown

Patent intelligence

$325M patent portfolio · 229 active families

Estimated portfolio value
$325M
57.2% of market cap · comparable to top peer Translate Bio ($371M)
229 active patent families
Where Ginkgo Bioworks innovates Molecular biologyMicrobiologyBiological organismBiotechnologyBioinformatics

Where Ginkgo Bioworks concentrates vs peers

Each axis is a top-10 topic across Ginkgo Bioworks and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Ginkgo Bioworks's 19 investments and acquisitions.

Every disclosed deal where Ginkgo Bioworks appeared as a backer or acquirer, 2017–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

19 deals across Ginkgo Bioworks's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Ginkgo Bioworks's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        19 of 19 deals

        Sentiment on X

        What X is saying about Ginkgo Bioworks

        An AI-synthesized read of the highest-engagement posts about Ginkgo Bioworks on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Ginkgo Bioworks on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.